Health
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store – Yahoo News Australia
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from…
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to dosing, including one where two full-strength doses were applied, which was 62% effective, and a much more promising dosage trial which used one half-dose and one full-strength dose to follow — that one was 90% effective.
Oxford’s results may not have…
-
Noosa News23 hours agoInside the final hours before Australian lawyer Christopher Saines died in Thai massage parlour
-
General21 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
Noosa News24 hours agoAustralian NFL player Laki Tasi comes home to convince kids to switch codes
-
Business23 hours agoHow $1,000 a month in this ASX ETF could turn into $500,000